These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 22014753

  • 1. Small molecular CD4 mimics as HIV entry inhibitors.
    Narumi T, Arai H, Yoshimura K, Harada S, Nomura W, Matsushita S, Tamamura H.
    Bioorg Med Chem; 2011 Nov 15; 19(22):6735-42. PubMed ID: 22014753
    [Abstract] [Full Text] [Related]

  • 2. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist.
    Narumi T, Ochiai C, Yoshimura K, Harada S, Tanaka T, Nomura W, Arai H, Ozaki T, Ohashi N, Matsushita S, Tamamura H.
    Bioorg Med Chem Lett; 2010 Oct 01; 20(19):5853-8. PubMed ID: 20728351
    [Abstract] [Full Text] [Related]

  • 3. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
    Narumi T, Arai H, Yoshimura K, Harada S, Hirota Y, Ohashi N, Hashimoto C, Nomura W, Matsushita S, Tamamura H.
    Bioorg Med Chem; 2013 May 01; 21(9):2518-26. PubMed ID: 23535561
    [Abstract] [Full Text] [Related]

  • 4. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y, Ochiai C, Yoshimura K, Tanaka T, Ohashi N, Narumi T, Nomura W, Harada S, Matsushita S, Tamamura H.
    Bioorg Med Chem Lett; 2010 Jan 01; 20(1):354-8. PubMed ID: 19926478
    [Abstract] [Full Text] [Related]

  • 5. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT, Meyer B.
    Angew Chem Int Ed Engl; 2004 May 24; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract] [Full Text] [Related]

  • 6. Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.
    Ohashi N, Harada S, Mizuguchi T, Irahara Y, Yamada Y, Kotani M, Nomura W, Matsushita S, Yoshimura K, Tamamura H.
    ChemMedChem; 2016 Apr 19; 11(8):940-6. PubMed ID: 26891461
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Flexibility of small molecular CD4 mimics as HIV entry inhibitors.
    Kobayakawa T, Ohashi N, Hirota Y, Takahashi K, Yamada Y, Narumi T, Yoshimura K, Matsushita S, Harada S, Tamamura H.
    Bioorg Med Chem; 2018 Nov 15; 26(21):5664-5671. PubMed ID: 30366786
    [Abstract] [Full Text] [Related]

  • 9. Synthetic mimetics of the CD4 binding site of HIV-1 gp120 for the design of immunogens.
    Franke R, Hirsch T, Overwin H, Eichler J.
    Angew Chem Int Ed Engl; 2007 Nov 15; 46(8):1253-5. PubMed ID: 17211914
    [No Abstract] [Full Text] [Related]

  • 10. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.
    Hsu ST, Bonvin AM.
    Proteins; 2004 May 15; 55(3):582-93. PubMed ID: 15103622
    [Abstract] [Full Text] [Related]

  • 11. Probing of CD4 binding pocket of HIV-1 gp120 glycoprotein using unnatural phenylalanine analogues.
    Yu X, Talukder P, Bhattacharya C, Fahmi NE, Lines JA, Dedkova LM, LaBaer J, Hecht SM, Chen S.
    Bioorg Med Chem Lett; 2014 Dec 15; 24(24):5699-5703. PubMed ID: 25453804
    [Abstract] [Full Text] [Related]

  • 12. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120.
    Gizachew D, Moffett DB, Busse SC, Westler WM, Dratz EA, Teintze M.
    Biochemistry; 1998 Jul 28; 37(30):10616-25. PubMed ID: 9692951
    [Abstract] [Full Text] [Related]

  • 13. A minimally cytotoxic CD4 mimic as an HIV entry inhibitor.
    Mizuguchi T, Harada S, Miura T, Ohashi N, Narumi T, Mori H, Irahara Y, Yamada Y, Nomura W, Matsushita S, Yoshimura K, Tamamura H.
    Bioorg Med Chem Lett; 2016 Jan 15; 26(2):397-400. PubMed ID: 26706175
    [Abstract] [Full Text] [Related]

  • 14. Design and optimisation of potent gp120-CD4 inhibitors.
    Tran TD, Adam FM, Calo F, Fenwick DR, Fok-Seang J, Gardner I, Hay DA, Perros M, Rawal J, Middleton DS, Parkinson T, Pickford C, Platts M, Randall A, Stephenson PT, Vuong H, Williams DH.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):5250-5. PubMed ID: 19632839
    [Abstract] [Full Text] [Related]

  • 15. Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction.
    Williams DH, Adam F, Fenwick DR, Fok-Seang J, Gardner I, Hay D, Jaiessh R, Middleton DS, Mowbray CE, Parkinson T, Perros M, Pickford C, Platts M, Randall A, Siddle D, Stephenson PT, Tran TD, Vuong H.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):5246-9. PubMed ID: 19620004
    [Abstract] [Full Text] [Related]

  • 16. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
    Caporuscio F, Tafi A, González E, Manetti F, Esté JA, Botta M.
    Bioorg Med Chem Lett; 2009 Nov 01; 19(21):6087-91. PubMed ID: 19783140
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of putative, stable binding regions through flexibility analysis of HIV-1 gp120.
    Tan H, Rader AJ.
    Proteins; 2009 Mar 01; 74(4):881-94. PubMed ID: 18704932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.